14:00-14:10

Welcome & Format Review

14:15-15:10

Aligning the “Why” and “How” of Compliance
Timothy Glynn, Seton Hall Law School (New Jersey)

15:15-16:05

Global Anti-Corruption Enforcement
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

16:05-16:20

Break

16:20-17:05

Being the Focus of a Government Investigation
Orlando Vidal, Norton Rose Fulbright (Dubai)
Giuseppe “Pino” Falbo, Takeda (Dubai)

17:10-17:55

Middle East Anti-Corruption Laws
Nicholas Cameron, KPMG (Dubai)

18:00- 18:30

Trade Sanctions and Export Controls
Borys Dackiw, Baker & McKenzie Habib Al Mulla (Abu Dhabi)

14:00-14:30

Data Protection in the Middle East Health Care Sector
Eamon Holley, DLA Piper (Dubai)

14:35-15:35

Global and Regional Industry Codes (Pharma & Device)
Arwa Asiri, Mecomed (Dubai)
Laura Nassar, Sanofi (Dubai)

15:35-15:50

Break

15:50-16:35

Middle East Transparency Trends & Challenges
Diva Duong, IQVIA (Paris)

16:40-17:25

Building an Effective Compliance Program
Robin Singh, Healthcare Government Entity (Abu Dhabi)

17:30-18:30

Compliance Officers' Panel Discussion
Giuseppe “Pino” Falbo, Takeda (Dubai)
Karina Griese-Brake, Fresenius Medical Care Middle East (Dubai)
Laura Nassar, Sanofi (Dubai)
Moderator: Timothy Glynn, Seton Hall Law School (New Jersey)

18:30-18:40

Case Study Assignments

Optional

Current Health Care Compliance Trends: Focus on Sub-Saharan Africa
Aissatou Niang-Diouf, Sanofi (Dakar)

Optional

Current Health Care Compliance Trends: Focus on Egypt
Dalia Adel Mohsen, Johnson & Johnson Egypt (Cairo)

14:00-15:00

Emerging Risk Area: Patient Support Programs
Ghada El Ehwany, Baker McKenzie, Helmy, Hamza and Partners (Cairo)
Els Janssens, Baker McKenzie (Brussels)

15:05-15:45

Assessing Third Party Risk
Speaker TBA

15:45-16:00

Break

16:00-17:30

Distributor Management Strategies in the Middle East
Lina Al Abbadi, Petra Drug Store (Amman)
Karina Griese-Brake, Fresenius Medical Care Middle East (Dubai)
Dalia Adel Mohsen, Johnson & Johnson Egypt (Cairo)
Moderator: Joe Henein, NewBridge Pharmaceuticals (Dubai)

17:35-18:30

Anti-corruption Settlements
John Kelly, Bass, Berry & Sims PLC (Washington, D.C.)
Fabiana Lacerca Allen, Aimmune Therapeutics (California)

Optional

Current Health Care Compliance Trends: Focus on India
Dr. Miland Antani, Nishith Desai Associates (Mumbai)
Darren Punnen, Nishith Desai Associates (Mumbai)

Optional

Country-Specific Session: Focus on Turkey
Filiz Toprak Esin, Gün + Partners (Istanbul)

12:00-14:30

Case Study Prep Session

14:30-15:00

Data-Driven Analysis for Compliance Programs
Ghaz Shah, Alvarez & Marsal Middle East Limited (Dubai)

15:05-15:55

The Importance of Culture and Ethics in Building and Growing a Compliance Team
Roeland Van Aelst, Johnson & Johnson (Antwerp)

15:55-16:10

Break

16:10-16:40

A Journey to the Dark Side of International Business: Real-World Risk and Real-World Lessons—Ask Richard
Richard Bistrong, Front-Line Anti-Bribery LLC (Connecticut)

16:45-18:15

Interactive Session- Part 2
Team Presentations & Classroom Discussion
Laura Nassar, Sanofi (Dubai)

18:20-18:30

Closing Remarks